CCSVI, MS & Alzheimer’s Disease
A Current Understanding of Alzheimer’s Disease and the Prospects of Phytopharmacological Intervention as a Management Strategy"

Juma KK*, Department of Biochemistry and Biotechnology, Kenyatta University, Nairobi

"...Conclusion

The numbers of people with AD are increasing over time. This has been associated with the presence of ineffective drugs targeting acetyl cholinesterase and N- methyl D- Aspartate receptors. However, the finding of chronic cerebrospinal venous insufficiency association with MS may offer a new green light which may also be evaluated in AD. The similarities between jneurodegeneration and inflammatory mechanisms between MS and AD have also been demonstrated. There is a great potential of phytopharmacological intervention in reversing vascular damage to tissue which promote CCSVI and offers a new therapeutic target for management of MS and therefore also AD. Already, phytopharmacological intervention in management of inflammatory reaction has been widely been researched. Hence, phytopharmacological intervention for management of AD offers great potential for management of AD. However, bioprospecting for potential herbal phytochemical extracts as possible drugs through rigorous research and clinical trials processes for bioscreening of prospective future drugs for management of Alzheimer’s disease targeting the inflammatory and in reversing vascular damage responsible for CCSVI. This will possibly offer a non-invasive, effective and low cost intervention in treatment and also reduce the ever rising cases of Alzheimer’s diseases. ."

http://www.esciencecentral.org/journals/a-current-understanding-of-alzheimers-disease-and-the-prospects-of-phytopharmacological-intervention-as-a-management-strategy-2329-6895-1000244.pdf